In the last three years, CellCentric CEO Will West has been on a journey that has transformed how he thinks about the future of his company. He used to be “obsessed with pharma deals,” he told Fierce Biotech. Now, the clinical-stage biotech has enough runway to stay independent and take its drug to market.